Compare Medtronic PLC (MDT) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Prudential Financial Inc — how do they compare? Medtronic PLC trades at $82.52 (market cap $106.61B), while Prudential Financial Inc trades at $118.36 (market cap $40.97B). The key difference: Medtronic PLC is far larger — about 2.6× Prudential Financial Inc's market cap, and Prudential Financial Inc pays the higher dividend (4.75%). Which is the better fit depends on your goals.
| MDT | PRU | |
|---|---|---|
Market Cap | $106.61B | $40.97B |
Sector | Health | Financials |
52-Week High | $105.35 | $119.07 |
52-Week Low | $73.75 | $92.00 |
Enterprise Value | $125.36B | $68.03B |
Dividend Yield | 3.46% | 4.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Prudential Financial (PRU) trades at $118.04, down 0.87% on the day, showing mixed technical signals with a bullish overall trend but overbought RSI indicators. Fundamentally, the company demonstrates solid profitability with 5.5% net income margin and 11.08% ROE, though revenue declined from $70.7B in 2024 to $61.0B in 2025. Recent earnings show beats in Q3 2025 and Q1 2026, with Q2 2026 results expected August 4, 2026.
The stock presents a value opportunity with attractive valuation multiples (P/E 12.26, P/S 0.67) but faces headwinds from analyst skepticism (67.57% hold rating) and a consensus price target of $102.50 below current levels. Key risks include revenue volatility and high debt levels, while catalysts include retirement market growth and international expansion driving long-term earnings potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
